BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6961433)

  • 1. Quantitative determination of dopamine receptor subtypes not linked to activation of adenylate cyclase in rat striatum.
    Huff RM; Molinoff PB
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7561-5. PubMed ID: 6961433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.
    Hamblin MW; Leff SE; Creese I
    Biochem Pharmacol; 1984 Mar; 33(6):877-87. PubMed ID: 6712712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of the interaction of [3H]spiroperidol with serotonin and dopamine receptors.
    McGonigle P
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S73-7. PubMed ID: 2459520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential affinities of molindone, metoclopramide and domperidone for classes of [3H]spiroperidol binding sites in rat striatum: evidence for pharmacologically distinct classes of receptors.
    Rosenfeld MR; Dvorkin B; Klein PN; Makman MH
    Brain Res; 1982 Mar; 235(1):205-11. PubMed ID: 6145486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S; Nahorski SR
    Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA; Altar CA; Wong CA; Marshall JF
    Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol.
    Altar CA; Kim H; Marshall JF
    J Pharmacol Exp Ther; 1985 May; 233(2):527-38. PubMed ID: 3889277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium ion modulates D2 receptor characteristics of dopamine agonist and antagonist binding sites in striatum and retina.
    Makman MH; Dvorkin B; Klein PN
    Proc Natl Acad Sci U S A; 1982 Jul; 79(13):4212-6. PubMed ID: 6213964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive method for the quantitative determination of dopamine receptor subtypes.
    McGonigle P; Huff RM; Molinoff PB
    Ann N Y Acad Sci; 1984; 430():77-90. PubMed ID: 6331265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine receptors in the goldfish retina: 3H-spiroperidol and 3H-domperidone binding; and dopamine-stimulated adenylate cyclase activity.
    Redburn DA; Clement-Cormier Y; Lam DM
    Life Sci; 1980 Jul; 27(1):23-31. PubMed ID: 6105607
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of binding sites for 3H-spiroperidol in human retina.
    McGonigle P; Wax MB; Molinoff PB
    Invest Ophthalmol Vis Sci; 1988 May; 29(5):687-94. PubMed ID: 2452802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assay of dopamine receptors with [alpha-3H]flupenthixol.
    Huff RM; Molinoff PB
    J Pharmacol Exp Ther; 1985 Jan; 232(1):57-61. PubMed ID: 3965700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of D-2 dopamine receptors in a tumor of the rat anterior pituitary gland.
    Lin C; McGonigle P; Molinoff PB
    J Pharmacol Exp Ther; 1987 Sep; 242(3):950-6. PubMed ID: 2958621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the binding of [3H]spiperone and [3H]domperidone in homogenates of mammalian retina and caudate nucleus.
    Watling KJ; Iversen LL
    J Neurochem; 1981 Nov; 37(5):1130-43. PubMed ID: 7299392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct target size of dopamine D-1 and D-2 receptors in rat striatum.
    Nielsen M; Klimek V; Hyttel J
    Life Sci; 1984 Jul; 35(3):325-32. PubMed ID: 6235424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]Ro 22-1319 (piquindone) binds to the D2 dopaminergic receptor subtype in a sodium-dependent manner.
    Nakajima T; Iwata K
    Mol Pharmacol; 1984 Nov; 26(3):430-8. PubMed ID: 6149457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
    Leff SE; Creese I
    Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of non-steroidal antiestrogens with dopamine receptor binding.
    Hiemke C; Ghraf R
    J Steroid Biochem; 1984 Dec; 21(6):663-7. PubMed ID: 6098784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine receptor binding in inbred mice: strain differences in mesolimbic and nigrostriatal dopamine binding sites.
    Boehme RE; Ciaranello RD
    Proc Natl Acad Sci U S A; 1981 May; 78(5):3255-9. PubMed ID: 6166945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.